https://gaeu.com/news daily 0.75 2026-02-19 https://gaeu.com/news/winning-the-eic-accelerator-once-is-hard-winning-it-twice-is-a-craft monthly 0.5 2026-02-19 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/62d9d188-3517-402b-a167-756fdbcf4a9b/Cellevate+%281%29.png News - Winning the EIC Accelerator once is hard. Winning it twice is a craft - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/westra-secures-65m-in-blended-funding-from-eic-accelerator monthly 0.5 2026-02-19 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/33e357d7-1575-4315-9452-4dd19f60501a/Westra+%281%29.png News - WESTRA secures €6.5M in blended funding from EIC Accelerator - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/ligna-energy-awarded-sek-8m-under-the-scaling-up-for-a-sustainable-battery-value-chain-programme monthly 0.5 2026-02-18 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/5469552f-0dea-4710-9f64-c5ef8349325e/Ligna+%281%29.png News - Ligna Energy awarded SEK 8M under the “Scaling Up for a Sustainable Battery Value Chain” programme - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/aventix-secures-vinnova-innovative-start-ups-grant monthly 0.5 2026-01-05 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/8d4bc200-e7d2-4da3-948d-f6fe342abada/Aventix.png News - Aventix secures Vinnova Innovative Start ups grant - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/linnovation-receives-sek-258m-in-funding-from-the-swedish-energy-agency monthly 0.5 2026-01-05 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/ad2662f4-4366-4d93-ba33-2b6f3d5acd77/Linnovation.png News - Linnovation receives SEK 2.58M in funding from the Swedish Energy Agency - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/pixelgen-technologies-secures-125m-in-blended-funding-from-the-eic-accelerator monthly 0.5 2025-11-05 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/cac9e153-347c-485f-9a3f-2d0a56ecd49e/Pixelgen.jpg News - Pixelgen Technologies secures €12.5M in Blended Funding from the EIC Accelerator - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/alzecure-pharma-secures-25-million-grant-from-eic-accelerator monthly 0.5 2025-06-30 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/e0de1625-72b9-4357-932c-fd734c6310d2/Alzecure_B.jpg News - AlzeCure Pharma secures €2.5M grant from EIC Accelerator - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/polbionica-receives-25-million-from-the-feng-seal-of-excellence-eic-accelerator-funding-program-in-poland monthly 0.5 2025-02-18 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/744dcc8c-0273-49eb-8f89-e47e5b6dfef2/Polbionica.jpg News - Polbionica receives €2.5M from the FENG Seal of Excellence EIC Accelerator funding program in Poland - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/cocoon-airbag-protection-receives-grant-from-womentecheu monthly 0.5 2024-10-29 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/495d2ae0-24bc-43e6-8140-d8ee02165118/Cocoon_B+%281%29.jpg News - Cocoon Airbag Protection Receives Grant from Women TechEU, Horizon Europe – the only Swedish start-up to be awarded funding in the latest round of the program - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/pharmnovo-awarded-175-million-from-eic-for-innovative-pain-treatment monthly 0.5 2024-09-17 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/c85cdfd0-78b0-4917-a60e-7f83ae694800/Pharmnovo.jpg News - PharmNovo awarded €17.5M from EIC for innovative pain treatment - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/alixlabs-and-partners-secure-400k-from-swedens-innovation-agency-vinnova-to-develop-cutting-edge-digitalization-platform-for-aps-semiconductor-technology monthly 0.5 2024-07-15 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/63d30a27-fc6b-40f3-92dc-0d5cb930c632/Alixlabs.jpg News - AlixLabs and Partners Secure €400k from Sweden's innovation agency Vinnova to Develop Cutting-Edge Digitalization Platform for APS Semiconductor Technology - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/compular-receives-53-million-in-blended-funding-from-eic-accelerator-horizon-europe-with-support-from-gaeu-consulting monthly 0.5 2024-05-27 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/9f3b8425-472c-4bc5-95d5-832bd67d3405/Compular.jpg News - Compular Receives €5.3M in Blended Funding from EIC Accelerator Horizon Europe with support from GAEU Consulting - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/gaeu-consultings-client-qlucore-secures-25-million-from-eic-accelerator-horizon-europe monthly 0.5 2024-04-16 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/cd51d125-2bd7-4970-a3b0-ed45a007fb65/Qlucore+%281%29.jpg News - GAEU Consulting’s Client Qlucore secures €2.5M from EIC Accelerator Horizon Europe - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/gaeu-supports-braincool-in-securing-125m-from-the-european-investment-bank-eib monthly 0.5 2024-02-27 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/68c9fd1c-bf17-41d1-9136-f4d6a4186ff3/Braincool.jpg News - GAEU supports BrainCool in securing €12.5M from the European Investment Bank (EIB) - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/upscaling-for-a-sustainable-industry monthly 0.5 2023-12-22 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/2f8e864a-1f28-4237-a623-c41907236159/Vinnova.jpg News - €2M for GAEU’s clients from Upscaling for a sustainable industry 2023 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/ipercept monthly 0.5 2023-06-20 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/ea2528ee-72b4-4189-ac0b-6f0ba7a920fd/IPercept.jpg News - IPercept Technology AB receives 3.5M SEK from Vinnova (Advanced and innovative digitalization) - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/multi4-medical-ab monthly 0.5 2023-05-08 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/9231c57d-de71-4e6a-abcc-6e09fbb73b69/Multi4_B%281%29.jpg News - Multi4 AB receives grant from WomenTechEU, Horizon Europe - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/tendo monthly 0.5 2023-04-20 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/34b39235-e399-48f2-9580-1841db18a823/Tendo.jpg News - Tendo AB gets EUR 300k funding from Swelife and Medtech4Health - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/inossia monthly 0.5 2023-04-03 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/fb40cb07-8f85-4406-b873-4ceb2b988cff/Inossia.jpg News - GAEU supports Inossia in securing 7.3 MEUR from EIC Accelerator - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/ligna-energy monthly 0.5 2023-03-30 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/943e5980-da16-4405-9f0f-80925918aa2f/Ligna+%282%29.jpg News - Ligna Energy and GPBM France receive Eurostars funding - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/highlights-2022 monthly 0.5 2023-02-09 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/f9afc0db-09bd-450a-862a-3963f66e95b4/GAEU+%283%29.jpg News - Highlights 2022 - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/cyto365-embedl monthly 0.5 2023-01-03 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/bf167250-4572-4e65-adcb-51713b0b404b/News.jpg News - 6.45 MEUR for GAEU Consulting’s Clients in the final 2022 cut-off of EIC Accelerator, Horizon Europe - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/minalyze-news monthly 0.5 2022-12-20 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/655bf1a3-4f8b-45be-adab-7b68a8fac883/Minalyze_B.jpg News - Minalyze receives EUR 350k from Vinnova - Advanced and innovative digitalization - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/seatwirl monthly 0.5 2022-12-15 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/c44c023e-414f-4504-9d92-3465ac625105/News+%281%29.jpg News - SeaTwirl receives 5 MEUR from the Swedish Energy Agency - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/lindhe-xtend monthly 0.5 2022-11-15 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/af44c581-0d07-4b1c-99d5-45cb3c28b065/Lindhe+Xtend.jpg News - GAEU Consulting secures the prestigious EIC Accelerator funding for Lindhe Xtend - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/genagon monthly 0.5 2022-10-28 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/c14f0536-8aed-44d7-a1ae-8d6346b5e854/Genagon.jpg News - Genagon Therapeutics and Mosaique Diagnostics receive Eurostars funding - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/greeniron monthly 0.5 2022-09-13 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/3e82231c-07ec-42b6-9350-f5b2f126ac95/Greeniron.jpg News - GreenIron and Copperstone Resources receive a prestigious grant from Vinnova - Upscaling for a sustainable industry - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/eurostars monthly 0.5 2022-09-13 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/a0e8480b-808a-4f55-b3c5-700b54e93a17/News.jpg News - EUROSTARS: 5.5 MEUR for GAEU’s clients - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/cellevate monthly 0.5 2024-03-21 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/eae0c0d5-c6ea-4d3a-9781-b6157e3c3cbd/Cellevate.jpg News - Cellevate secured a two-year €5.48M (in total) grant funded through EIC Accelerator program - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/elicera monthly 0.5 2022-09-14 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/4e7defd9-a50a-479e-b903-15e75936b8ce/Elicera_B.jpg News - Elicera Therapeutics got 2.5 MEUR grant to finance a clinical phase I/II-trial with CAR T-cell therapy - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/horizon-europe monthly 0.5 2022-06-08 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/3f5c080c-50d6-46a1-9ce9-2de3340d4d94/News_b.jpg News - EIT Hub Israel & GAEU Consulting cooperation resulted in winning grant within European Innovation Ecosystems (EIE) program - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/pulpac monthly 0.5 2022-06-01 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/a6c88404-1480-402f-a88c-f821ca8fedcd/Pulpac_B.jpg News - BioInnovation Grant secured for the greentech consortium led by PulPac - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/grant monthly 0.5 2022-06-01 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/e6f2343f-a904-4943-85bf-5752bb272ba2/2.7+MEUR+to+GAEU%E2%80%99s+clients%21%281%29.jpg News - EUROSTARS: 2.7 MEUR to GAEU’s clients! - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/survey monthly 0.5 2022-06-01 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/f58c74bd-de77-44b0-81f8-81814b6ec10a/Client+satisfaction+survey+%26+employee+survey.jpg News - Highest score in client & employee satisfaction survey - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/irras monthly 0.5 2022-06-01 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/4495a4b2-efe9-4457-b23b-6ef5be6ae6b6/IRRAS%281%29.jpg News - GAEU´s client IRRAS receives loan financing under EIB - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/realheart monthly 0.5 2022-06-08 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/9ea625be-21b4-454a-960e-187eb3432e98/Realheart+-+GAEU+Consulting+secures+a+prestigious+Eurostars+grant%282%29.jpg News - Scandinavian Real Heart and Berlin Heart GmbH secured Eurostars grant for the deep tech consortium - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/minalyze monthly 0.5 2022-06-01 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/cbc255fb-807c-4037-b1e7-a2923d8f7bae/Minalyze+-+GAEU+Consulting+supports+Minalyze+in+securing+EUR+4M+from+the+European+Innovation+Council+%28EIC%29%281%29.jpg News - GAEU supports Minalyze in securing 4M from EIC - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/news/gaeu-supports-ukraine monthly 0.5 2022-06-01 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/623c7eb0-e65c-474f-9e44-05496a42c78c/GAEU+supports+Ukraine.jpg News - GAEU supports Ukraine - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://gaeu.com/articles daily 0.75 2023-02-13 https://gaeu.com/articles/excel-gaeu-interest-function monthly 0.5 2023-02-13 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/93ac062a-ad2f-4881-9c2f-466575cd0ee8/financial-manager.jpg Articles - Excel GAEU interest function https://gaeu.com/articles/building-and-maintaining-a-successful-consulting-team monthly 0.5 2022-10-26 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1664803735513-XT28S0TURH8KGTM99U4R/Articles.png Articles - Building and maintaining a successful consulting team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/163570d0-044b-460d-ba1e-875c8cad7c19/operations-manager.jpg Articles - Building and maintaining a successful consulting team https://gaeu.com/team daily 0.75 2025-02-27 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1654603321321-I6BA2P4R34NK5VMO52MT/Roland%2BVilhelmsson.png Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1654603538334-Y1I1J73RAKD4GZ5E7HSG/CEO.jpg Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1654603680377-MXT6G6QZXG55RCW5GV98/financial-manager.jpg Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1654603933174-SGNNP8HOQWN203S14DMD/operations-manager.jpg Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1654604213137-GZX4CEJ5GDNOFF06UAVP/Jonas%2BBohman.png Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1654604519214-LQK25AMU0AYW938XSOKW/senior-research-and-development-consultant.jpg Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1654605358137-WLLYYOOWOZX7E1OO3819/graphic-designer.jpg Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/2b145add-6070-49ff-825d-97dca2d05fe6/research-and-development-consultant+%283%29.png Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/378ac1fd-b0ff-4bb5-9fd8-38bf9acee6a0/Gregory-Kolodziej-research-and-development-consultant.png Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/53b23342-26a7-4a2e-902c-031de8b471db/Malgorzata-Honc-research-and-development-consultant.png Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/d126446c-b153-4530-8cfc-fa606f9922ff/Magdalena-Kurtyka-research-and-development-consultant.png Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/7ef2eb76-3e62-4d8b-aaaf-a16b9f776c0c/Oskar-Malmsj%C3%B6_B.png Team https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/8c2dd7f7-1c0b-445a-8f62-e6984d9dd3c3/Jonathan-Schauman.png Team https://gaeu.com/personal-data-processing-policy daily 0.75 2023-01-05 https://gaeu.com/home daily 1.0 2026-02-19 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1652686044750-LXCKLVH3T3PBKG9E9WXK/Minalyze.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1652686194187-8MNV98DG893TKG4V7O7L/Multi4+%282%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1652686299404-MIYP3K1FJ8M3I1BK22K6/Vicore+Pharma+%282%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1653899279336-KVOKF6KW01U0LNB7XRUT/Cellink.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1653911257230-U9P3XZE2VWBG6I87ZFT7/Kopia+References+with+logo_C.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1654612635698-2CYFOEN7J770NO1KVHQT/Cellevate.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1663143071119-J53R4EHVX61O06PKC2AI/Genagon_B.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1654165145707-BHMOG1GTNET8V6WYKBZ0/Elicera.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/55bce3b9-e088-4b07-a2e8-76340282b5e7/Greeniron.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/0dc26074-1176-4e20-a214-7e46496c16c9/LindheXtend_B.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1668531316188-HDA4OXXYC6BU9MO4HS32/News+%281%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/80e25384-374c-45ea-9de8-251381dd16cf/Seatwirl.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/33d262a7-9691-4400-91a0-e5606f249924/Embedl.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/98562c20-1bf7-4664-a030-ab5586fc17ef/Cyto.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1671527941108-H3WKYY5Q8UF4149T3O1P/News+%281%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1672834220056-Y88RZDBRCCKPHR3VY3G6/GAEU+%283%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/6b6c96bc-2082-47ec-a09f-9932d049133e/Ligna+%282%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/2681c5ef-4396-4dbb-b47a-4c4615b3680b/Ligna.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/ae0b5f09-838d-480d-bc7f-1110dabacecd/Inossia.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/d89a852d-3d6a-4c30-8dcf-42b12cdb4aaf/Inossia+%282%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/9756cd26-ddae-402e-89c3-135cece9622e/Tendo.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1255257b-690b-4498-a343-f5a3c76ff6c0/Multi4_B%281%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/7cadb40e-e767-4e34-ab6b-f251e86f3dd7/Multi4%281%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1683531682445-A99WTYNJY705FYFSQTGD/IPercept.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1687252247654-QY810WKYJTYCYBNMW1OA/Vinnova.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1703248560599-J09EGCZK67MMY8475IPY/Braincool.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/4bc76454-5c9d-40ca-be80-2249409e10c9/Qlucore+%281%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/cfd57b9f-45cf-4f77-a50c-fae688149c08/Qlucore.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/55330c5f-4d74-48a3-8436-83bffed082cb/Compular.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/f1e17f12-f2d0-49f6-a056-8bcbd68e47a8/Compular+%281%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/7748cfe8-3247-489b-aa11-9f79d602c6fb/Braincool.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/9503bf19-5b24-469e-b9b7-4da985588751/Alixlabs.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1721114098661-PA0YBQ8KYWAGCTZ71VDR/Pharmnovo.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/ad15aa32-db88-4562-814e-d2ec595837bf/Pharmnovo_B.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/a5807180-ade4-4b97-bdd1-55e0c3770db5/Cocoon_C.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1730186731295-92PZSEBBA2TOS1R4OOZG/Polbionica.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1739865444087-4S6N15ITUDSEV0G1Q5N2/Alzecure.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/34135b6a-45e0-435e-9890-8e6832a4a850/Alzecure_B.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1751274173791-S5QS1WNEEEIWIR7UO1BG/Pixelgen.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/da39561e-07c1-4e5e-8359-6707e0d55128/Pixelgen+%281%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1762329880482-22GY8VIAVTF362NAV7K4/Linnovation.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/f158407a-7ad3-46a7-afc6-8ac5f81ea345/Linnovation+%283%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1767624531276-JCRBC6A91P04JMSLNIXE/Aventix.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1767625114646-K43OLFZD3RNS2OGAZM14/Ligna+%281%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1771409005364-U38VU64VOVOTJS78XD0B/Westra+%281%29.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/c8abd44d-6f4d-4ff0-98c2-c37e838d4ff6/Westra.png Home https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1771504767901-Z8EIX6BQFO9WJ2ZBSEUD/Cellevate+%281%29.png Home https://gaeu.com/about-us daily 0.75 2023-09-05 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650538571425-HR0DCHC237K4CHEJZNYL/Founders_Alliance_logo.png About Us https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650538601442-DM4ZNU4LMSG58WMK0GM4/Medicon_Village_logo.png About Us https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650612424531-8LZ1PBI1YNA9NWBERHMG/Connect_logo.png About Us https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1651578784171-O8TYJ3ABX554WLE2IQD3/EIT_Hub_Israel_logo.png About Us https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1653657325498-8BI7W22PK4M2PN3HWOCU/Projekt+bez+tytu%C5%82u+%281%29.png About Us https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650363463406-LTK146X3W6YIYND0T8DG/gaeu-consulting.jpg About Us GAEU Our vision: To become the European landmark for public financing of innovative projects. Our mission: In a world of ever-growing challenges, the mission of GAEU is to stimulate the growth of innovative solutions for the benefit of the world. Our business idea: To help growing businesses in terms of professional advice concerning grant funding, venture capital and the commercialization of innovations. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/eb34fafc-e2fd-40f5-8716-c68ef79320dc/GAEU-CEO.jpg About Us A word from the CEO Our specialty is a unique ability to combine private capital raising with competitive applications for EU grants and other public funding. In this way, we help hundreds of growing innovative companies every year to reach their business goals and at the same time do good for the environment and for humanity. Roland Vilhelmsson, Founder and CEO https://gaeu.com/recruitment daily 0.75 2026-02-16 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/6c061b14-5a7b-475c-b5d3-80743f0a70bc/SNC09395+%282%29.jpg Career https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/b7d67388-0d60-496d-97aa-ef453daf0569/SNC08949+%281%29.jpg Career https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/6fe7301a-206f-4e27-810c-0b644e416ed9/_H8A8350_V2.jpg Career - "Joining GAEU Consulting was a real life-changing event in my professional development. After 9 years at the university, I was looking for an opportunity to work at the intersection of science and business, closer to the commercial side of scientific innovations. GAEU was an excellent choice. Now, every day I have a chance to work with the most innovative European companies developing products that will transform our lives! This is the place where I always wanted to be." — Kamil Deryło https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1d475771-0165-4788-9cbf-2c23e7485dd5/SNC09082.jpg Career - “At GAEU, we believe that 'quality is the best business plan'. Combination of unique skills on the market with years of experience and enthusiasm is our offer to the clients and people who want to join our team.” — Joanna Szepelak-Frydrych https://gaeu.com/client-references-old daily 0.75 2022-04-27 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1648538989442-0HSNM8PPMUUK6BEKYOR2/Screenshot+2021-08-17+at+14.07.59.png Client References (old) - All Client References Read about all our success stories https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1648538989445-X614RUNQMPG4CI2ZNC21/Epinovatech-Green+Chip.jpg Client References (old) - Life Science Life science is a key…….. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1648538989449-7J648SVC3W6DH0HI46GB/FineCell+nanocellulose.jpg Client References (old) - Cleantech Cleantech is a key….. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1648538989453-OW93IHFM2NFEYXEJP3K2/polar-light-quatro-structure-1-e1606121101591.jpg Client References (old) - ICT ICT is a key….. https://gaeu.com/apply daily 0.75 2023-11-03 https://gaeu.com/our-offer daily 0.75 2025-02-26 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/3be42b03-b992-4aa4-8390-0b81b958dbbd/Corporate-finance_B.png Our Offer - Corporate Finance for Unlisted SMEs The specialty of our Corporate Finance department is a unique ability in the raising of private capital combined with competitive applications for EU grants or other public funding. This often involves strategic advice on how to optimize the business case and subsequently transforming it into an attractive investment case. This allows our clients to achieve their business goals faster and with lower risk while minimizing dilution effects. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/b0abbcb8-1ce9-43a0-a670-087add0140fc/grant-analysis.jpg Our Offer - Grant analysis and project positioning We will analyse your project, position your innovation on the TRL (Technology Readiness Level), MRL (Market Readiness Level), and SRL (Sustainability Readiness Level) scale and identify the most suitable and relevant funding option available on the market, exploring national and European funding programmes. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/73b84389-6212-41cb-9ac2-ab01813c75ca/grant-applications.png Our Offer - Grant & Equity applications within EU Funding We prepare the funding application that stands out, with a strong focus on the scientific merits, business, and financial dimensions of your business case. The application is developed to meet the requirements of the most demanding project assessment criteria in EU funding and venture capital. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/4098dd16-332a-49ba-bef0-d35a3b2e08a1/loan-funding.jpg Our Offer - Loan and venture debt funding We deliver loan and venture debt applications and guarantee support during discussions with banks and subsidiaries. Our services are based on high quality financial modelling. We deliver loan and venture debt applications and support our Clients through the due diligence process and contract negotiations with the banks and other funding bodies. The services include the development of professional financial models and business plans. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/ae33a3e4-7dad-461e-8572-a20777cca908/consulting-services.png Our Offer - Advisory Services We provide strategic consultancy support during all stages of proposal development, including alignment of the project with the requirements of the call, consortium structuring, application text review, budget consultation, development of consortium agreement, and grant agreement negotiation. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/58a875fe-8c31-4ed4-97d3-21c975fe25c9/project-reporting.jpg Our Offer - Project reporting We deliver assistance in project reporting and navigate our clients through this process. We support preparation of financial and technical project reports. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/ad773fc4-f812-4e29-8ab4-245ccd393c33/horizon-europe-logo.png Our Offer - Horizon Europe Horizon Europe is the EU's key funding programme for research and innovation, with a budget of €95.5 billion. The majority of funding schemes target top-class international consortia where partners co-develop ground-breaking technologies that boost the EU’s competitiveness and growth. Minimum funding ticket size: 0.5 MEUR https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/dbfe2ed5-32b3-4482-8c46-287285c6c9f6/eic-logo.png Our Offer - EIC Accelerator EIC Accelerator supports high-risk, high-reward, breakthrough projects pursued by European SMEs with ambitions for fast international growth. Different funding options available: grant first, grant only, blended funding (grant + equity investment). Three-stage application process: Step 1 proposal (continuous submission), Step 2 proposal to defined cut-offs, interview. Grant: EUR 0.5 to EUR 2.5 million Equity Component: EUR 0.5 to 15 milion https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/429ca18f-a943-443f-ae42-ec0558fc45d4/Women_tech.png Our Offer - Women TechEU Women TechEU is a part of the European Innovation Ecosystems work programme of Horizon Europe. Program is directed to women applicants who must have founded or co-founded an early-stage deep-tech start-up, and have to hold a top management position (CEO, CTO, COO or CFO) in the company. The company must be registered and established in an EU Member State or Associated Country for at least six months at the time of the submission. Individual grant of: EUR 75 000 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/0e634033-c859-454c-9023-f4d0514628d7/eureka-logo.png Our Offer - Eureka Eureka is the global public network for cooperation in R&D and innovation. It facilitates financing of collaborative R&D projects in a broad variety of fields, including life sciences, ICT, green-tech, and engineering projects. Eureka includes 48 countries in Europe and beyond who provide national funding to organisations who apply through Eureka programmes. Funding: from EUR 200k per project https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/0b3539d0-c1ce-4047-a583-c8be264159f2/eurostars-logo.png Our Offer - Eurostars Eurostars is the largest international funding programme for SMEs that aim to collaborate on R&D projects that create innovative products, processes or services for commercialisation. The Eurostars project requires a consortium of at least two partners from two different Eureka network countries. Partners can include SMEs, large companies, universities, and research centres. Grant: EUR 500k https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/959cbe92-9832-4dbb-b6a7-308033dd5f3d/eib-logo.png Our Offer - EIB funding EIB offers a broad variety of funding instruments, including loans, venture debt, or guarantees in support of SMEs or mid-caps. EIB targets companies with strong and sustainable business models, professional management team, and established corporate governance. The projects need to support the implementation of European policies and have a clear European dimension. Large tickets – EUR 7.5M – EUR 50M https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/8b73ecf7-d2da-452b-b59f-a5f18098edda/eit-health-logo.png Our Offer - EIT Health EIT Health manages a number of programs that offer SMEs and start-ups opportunities to learn new skills, connect with venture investors, broaden their industry network, and access new markets. Examples of popular programs include “Investor Network” which connects qualified companies seeking early-stage funding with the first pan-European consortium of more than 80 healthcare investors, or “EIT Health Bootcamps” which runs incubation programs for start-ups. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/d9fa0240-3c64-466f-8f1a-9cef77abc2cb/life-logo.png Our Offer - Life The LIFE programme is the EU's funding instrument for the environment and climate action. The most interesting offer to businesses is funding to large-scale demonstration projects that pilot new ground-breaking technologies and processes with clear positive environmental impact. Examples of relevant fields include circular economy, waste management, water preservation, etc. Grant: EUR 3-5 million https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/ee7b58b2-dd8c-407d-825d-245baaf38170/vinnova-logo.png Our Offer - Vinnova Vinnova is Sweden’s innovation agency that funds research and innovation projects that can benefit society. The programs include single applicant funding schemes, as well as funding directed towards value-adding consortia of partners and stakeholders from industrial value chains. Grant: EUR 0.2-2 million https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/b55e0e63-8c24-47fd-b251-b8011d43e358/swedish-energy-agency-logo.png Our Offer - Swedish Energy Agency The Swedish Energy Agency supports research and development projects in the fields of supply, conversion, distribution and use of energy. Funding is also provided to development of new green and sustainable technologies and processes. Grant: EUR 0.4-5 million https://gaeu.com/contact daily 0.75 2024-11-18 https://gaeu.com/all-client-references-old2 daily 0.75 2022-04-22 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1648538989445-X614RUNQMPG4CI2ZNC21/Epinovatech-Green+Chip.jpg All Client References (old2) - Colzyx: €2.5M t Colzyx has used GAEU for both the Phase 1 SME Instrument and the Phase 2 Accelerator – both applications were granted. We have found GAEU to be very professional, dedicated and skilled. In addition, the atmosphere in collaboration with GAEU has been characterized by openness and a strong commitment to creating the best possible project proposals. Colzyx was granted € 2,5 million from the Horizon 2020 EIC Accelerator Pilot Phase 2 programme. Dr. Eskil Söderlind, CEO https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1648538989449-7J648SVC3W6DH0HI46GB/FineCell+nanocellulose.jpg All Client References (old2) - Betagenon: €1.8M t In the application process, GAEU Consulting has proven itself to be a first class life science advisor, showing excellent understanding of our candidate drug and forces driving commercialization of medicinal products. GAEU has taken the leading role in shaping strategies behind our proposal, which resulted in the total scoring of 14.64 out of 15 – an almost perfect proposal. Based on my experience in cooperating with GAEU, I strongly recommend them as Horizon 2020 advisors. - Thomas Edlund Ph.D., Prof. Founder, Chief Executive Officer https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650442010897-KES7C94RZAK776QPSSII/polar-light-quatro-structure-1-e1606121101591.jpg All Client References (old2) - Cellink: €2.5M The company focuses on the development and commercialization of bioprinting technologies that allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products, and in the future, for clinical applications. Cellink was granted € 2.5M from the SME Instrument HORIZON 2020, phase 2. “Collaborating with GAEU has been great! The team is very responsive, knowledgable, and supportive. Their work and efforts will help us ensure long term success. A company to depend on.” - Erik Gatenholm, CEO https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650455065844-461AHSZKM1IMRPFY1RSK/Cellink_logo.png All Client References (old2) - CombiGene AB: €3.3M By combining modern neuroscience with recent advances in gene delivery, CombiGene has developed a method shown to suppress epileptic seizures in preclinical studies. CombiGene was granted €3.3 million from the SME Instrument HORIZON 2020, phase 2. “GAEU has in a significant way contributed to the successful outcome of our Horizon 2020-application. Both their experience of the complex application procedure and the professional hands-on support that we got throughout the entire process were very valuable. I look forward to a continued cooperation with them in the future.” - Jan Nilsson, CEO, CombiGene https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650455183663-A1ZLVKC5QMG7SK6JXK78/Cellink_logo.png All Client References (old2) - SenzaGen: €2.4M At SenzaGen, we have strong ambitions to grow and enable animal-free, cell-based systems to assess hazards and potency of industrial compounds. The grant we have received will be the perfect catalyst for this vision. We will use the funding to bring an innovative product to the market, with potential to become the cornerstone of our long-term competitiveness. For a small life science company, a grant covering 100 % of the project costs is of unparalleled value. We would like to thank GAEU for supporting us to secure this grant. We have received excellent guidance and advice in the application process. The team responsible for our proposal was easy to work with and very knowledgeable. GAEU is an excellent Horizon 2020 advisor and long term business partner. - Anki Malmborg Hager CEO https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650455287924-4ZKN319YC1RZBX2J0TQN/Cellink_logo.png All Client References (old2) - Corline Biomedical: €2.3M Corline, founded in 1991, develops, manufactures and markets heparin based solutions to improve kidney transplantation, cell therapies and applications in the evolving field of regenerative medicine. Coreline was granted € 2.3M from the SME Instrument HORIZON 2020, phase 2. “This is absolutely fantastic for Corline! This grant is one of the highest allocations awarded to a Swedish life science company within SME Instrument and it will allow us to fully fund our entire clinical study on Renaparin®. Apart from the purely practical and economic implications, it is also a great recognition of our project. It is really encouraging that the European Commission has recognized the potential in our project. With this grant, we will be able to create a platform from which we can accelerate Corline’s growth in kidney transplantation and new indications. GAEU Consulting has been our advisor throughout the entire application process and wrote our grant application. The outstanding application scoring received is proof to the quality of their service. I highly recommend GAEU as Horizon 2020 advisors for Life Science companies.” - Henrik Nittmar, PhD CEO https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650455437745-KUU7M1JTD4HIVGGPQD8T/Cellink_logo.png All Client References (old2) - Ilya pharma AB: €3.0M Ilya Pharma, an innovative Swedish pharmaceutical company, develops drug candidates for Proof of Concept in clinical phase I and II from its technology platform of lactic acid bacteria expressing different human therapeutic proteins. Ilya Pharma was granted € 3M from the SME Instrument HORIZON 2020, phase 2. “The cooperation with GAEU has been very successful with Ilya Pharma. GAEU’s consultants handled the process excellently. They possess eminent knowledge on how to break down a very complex project into smaller, logical activities, and on how the different parts are connected. It feels very good to have GAEU standing beside us in the process when we are to deliver this 18 months project” - Evenlina Vågesjö, CEO, Ilya Pharma https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650455523225-N3I75B52WVLLZHHJI5BG/Cellink_logo.png All Client References (old2) - Klaria AB: €2.0M Klaria’s business concept is based on developing and commercialising innovative products with clear competitive benefits in the therapeutic fields of migraine and cancer-related pain. Klaria received € 2M from the SME Instrument HORIZON 2020, phase 2. “Working with GAEU has provided the necessary structure and balance to our application. Their experience in emphasizing and bringing out the broader potential of our innovation and expressing that potential in clear text has been the most valuable part of our interaction. Navigation of the H2020 application process is complex, but with the help of GAEU, Klaria has been able to focus on bringing out key points in the broad potential of our innovation and critically, will aid in our presentation of our company in discussions with investors and shareholders outside of the context of H2020.” - Dr. Scott Boyer, CEO, Klaria https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650455610461-ILQQ00AB5YNDZX0UA4VJ/Cellink_logo.png All Client References (old2) - Idogen: €2.9M Idogen’s technology platform allows cells from the patient’s blood to be reprogrammed outside the body to dendritic cells with the capacity to specifically counteract adverse immune reactions. Idogen was granted € 2.9M from the SME Instrument HORIZON 2020, phase 2. “We warmly recommend GAEU Consulting services to Life Science companies seeking professional advice within Horizon 2020 funding.” - VD Lars Hedbys https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650455911800-C0LIJ8HDIR7XJDS3FXTD/Cellink_logo.png All Client References (old2) - Scandinavian Biopharma: €3.0M Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, immunoglobulin’s, biodefense, antidotes and diagnostic tests. Scandinavian Biopharma received € 3.0M from the SME Instrument HORIZON 2020, phase 2. “The contribution from the EU Commission is a strong recognition of our research, which strives toward developing a globally unique ETEC vaccine. The EU grant will be used to accelerate the clinical development of the vaccine and to take a significant step towards commercialisation. GAEU Consulting has been responsible for our application. We are very satisfied with the quality of the work effort and commitment from the team in Kraków” - Björn Sjöstrand, CEO, Scandinavian Biopharma https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650456021753-6JZLYDCAIWTV6VG8TPLQ/Cellink_logo.png All Client References (old2) - Targeted Immunotherapies: €2.7M The company develops the Tailored Leukapheresis (TLA) immunotherapy for immune mediated inflammatory diseases (IMIDs), which has demonstrated proof-of-concept in a Phase I/II clinical trial on inflammatory bowel disease (IBD). TLA was granted € 2.7M from the SME Instrument HORIZON 2020, phase 2. GAEU helped structuring the project, limiting the scope and building business argumentation. We made a grand contribution to the successful process by preparing the client for the pitch deck and interview in Brussels. We also created the presentation needed. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650456101314-QN804K9X61WOBB9ECYG5/Cellink_logo.png All Client References (old2) - Vitrolife: €348k For an innovative project in stemcell media, the listed biotech company Vitrolife AB was granted € 348,000 from the popular Research & Grow programme. GAEU helped us with the successful application. One of Vinnova’s examiners said it was the best application they had ever read. - Stefan Blomsterberg, Director of Strategic Projects https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650456147199-EF5HGT7ET3O949TDSM2X/Cellink_logo.png All Client References (old2) - Verigraft: €2.2M Verigraft is active in the field of regenerative medicine by developing personalized human tissues for transplantation. VERIGRAFT was granted € 2.2M from the SME Instrument HORIZON 2020, phase 2. “The SME Instrument funding represents an important element on our way to the next level of development and we are very proud to have been promoted to the SME Champions league. The VERIGRAFT team is very thankful for this reward of our rock-solid commitment and we are highly motivated to make this project a great success. This funding will facilitate our high ambitions to develop novel products that can help millions of patients with today incurable diseases.” - Dr. Petter Björquist, CEO, VERIGRAFT https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650456211136-I39ZJCK7XSYUIGSVKBZS/Cellink_logo.png All Client References (old2) - Gearwheel: €190k “Gearwheel is working on the development and sale of interchangeable wheelchairs, which make it easier for muscularly fragile users to move their own wheelchair. We are still an R&D intensive company and therefore have a clear need for external financing. GAEU helped us with an R&D application that resulted in a contribution of nearly SEK 2 million from Vinnova, which was a very important piece of the puzzle to secure our financing until major commercial revenue is generated from our new product.” - John-Edvard Stenstrand, CEO https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650456274929-CB36DUMD7T6ONLVHT6IR/Cellink_logo.png All Client References (old2) - Beactica: €50k Beactica is a specialist drug discovery company utilising its proprietary methodologies to evaluate the interaction of molecules in order to generate novel therapeutics. Beactica was granted € 50k from the SME Instrument HORIZON 2020, phase 1. GAEU helped structuring the project and highlight the parts essential in order for the commission to see the potential of the project, even though it was at a very early stage in its development, and very venturous. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650456336060-YWIR5T3S1VWGCGPZE6QL/Cellink_logo.png All Client References (old2) - BiBBinstruments: €50k BiBBInstruments AB offers innovative, disposable instruments under the brand name EndoDrill® for earlier and more accurate diagnosis in the most common forms of cancer. BiBBinstruments was granted € 50k from the SME Instrument HORIZON 2020, phase 1. GAEU helped structuring the project and highlight the parts essential in order for the commission to see the potential of the project, even though it was at a very early stage in its development, and very venturous. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/1650456408275-401QGT288G76141LWXVR/Cellink_logo.png All Client References (old2) - Cytacoat: €50k CytaCoat has developed a unique and stable antimicrobial coating that uses non-toxic, biocompatible organic compounds that strongly bind to the surface of the device through covalent bonding. Cytacoat has been granted EUR 50k from SME Instrument Phase 1. GAEU helped structuring the project and highlight the parts essential in order for the commission to see the potential of the project, even though it was at a very early stage in its development, and very venturous. https://gaeu.com/information-about-data-administration daily 0.75 2022-05-31 https://gaeu.com/our-offer-1 daily 0.75 2023-08-16 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/b0abbcb8-1ce9-43a0-a670-087add0140fc/grant-analysis.jpg Our Offer_B - Grant analysis and project positioning We will analyse your project, position your innovation on the TRL (Technology Readiness Level), MRL (Market Readiness Level), and SRL (Sustainability Readiness Level) scale and identify the most suitable and relevant funding option available on the market, exploring national and European funding programmes. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/73b84389-6212-41cb-9ac2-ab01813c75ca/grant-applications.png Our Offer_B - Grant & Equity applications within EU Funding We prepare the funding application that stands out, with a strong focus on the scientific merits, business, and financial dimensions of your business case. The application is developed to meet the requirements of the most demanding project assessment criteria in EU funding and venture capital. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/4098dd16-332a-49ba-bef0-d35a3b2e08a1/loan-funding.jpg Our Offer_B - Loan and venture debt funding We deliver loan and venture debt applications and guarantee support during discussions with banks and subsidiaries. Our services are based on high quality financial modelling. We deliver loan and venture debt applications and support our Clients through the due diligence process and contract negotiations with the banks and other funding bodies. The services include the development of professional financial models and business plans. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/ae33a3e4-7dad-461e-8572-a20777cca908/consulting-services.png Our Offer_B - Advisory services We provide strategic consultancy support during all stages of proposal development, including alignment of the project with the requirements of the call, consortium structuring, application text review, budget consultation, development of consortium agreement, and grant agreement negotiation. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/58a875fe-8c31-4ed4-97d3-21c975fe25c9/project-reporting.jpg Our Offer_B - Project reporting We deliver assistance in project reporting and navigate our clients through this process. We support preparation of financial and technical project reports. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/b6d892a3-3361-43b1-8e1a-49fd40ac7aac/Corporate-finance.png Our Offer_B - Corporate finance Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/ad773fc4-f812-4e29-8ab4-245ccd393c33/horizon-europe-logo.png Our Offer_B - Horizon Europe Horizon Europe is the EU's key funding programme for research and innovation, with a budget of €95.5 billion. The majority of funding schemes target top-class international consortia where partners co-develop ground-breaking technologies that boost the EU’s competitiveness and growth. Minimum funding ticket size: 0.5 MEUR https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/dbfe2ed5-32b3-4482-8c46-287285c6c9f6/eic-logo.png Our Offer_B - EIC Accelerator EIC Accelerator supports high-risk, high-reward, breakthrough projects pursued by European SMEs with ambitions for fast international growth. Different funding options available: grant first, grant only, blended funding (grant + equity investment). Three-stage application process: Step 1 proposal (continuous submission), Step 2 proposal to defined cut-offs, interview. Grant: EUR 0.5 to EUR 2.5 million Equity Component: EUR 0.5 to 15 milion https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/429ca18f-a943-443f-ae42-ec0558fc45d4/Women_tech.png Our Offer_B - Women TechEU Women TechEU is a part of the European Innovation Ecosystems work programme of Horizon Europe. Program is directed to women applicants who must have founded or co-founded an early-stage deep-tech start-up, and have to hold a top management position (CEO, CTO, COO or CFO) in the company. The company must be registered and established in an EU Member State or Associated Country for at least six months at the time of the submission. Individual grant of: EUR 75 000 https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/0e634033-c859-454c-9023-f4d0514628d7/eureka-logo.png Our Offer_B - Eureka Eureka is the global public network for cooperation in R&D and innovation. It facilitates financing of collaborative R&D projects in a broad variety of fields, including life sciences, ICT, green-tech, and engineering projects. Eureka includes 48 countries in Europe and beyond who provide national funding to organisations who apply through Eureka programmes. Funding: from EUR 200k per project https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/0b3539d0-c1ce-4047-a583-c8be264159f2/eurostars-logo.png Our Offer_B - Eurostars Eurostars is the largest international funding programme for SMEs that aim to collaborate on R&D projects that create innovative products, processes or services for commercialisation. The Eurostars project requires a consortium of at least two partners from two different Eureka network countries. Partners can include SMEs, large companies, universities, and research centres. Grant: EUR 500k https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/959cbe92-9832-4dbb-b6a7-308033dd5f3d/eib-logo.png Our Offer_B - EIB funding EIB offers a broad variety of funding instruments, including loans, venture debt, or guarantees in support of SMEs or mid-caps. EIB targets companies with strong and sustainable business models, professional management team, and established corporate governance. The projects need to support the implementation of European policies and have a clear European dimension. Large tickets – EUR 7.5M – EUR 50M https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/8b73ecf7-d2da-452b-b59f-a5f18098edda/eit-health-logo.png Our Offer_B - EIT Health EIT Health manages a number of programs that offer SMEs and start-ups opportunities to learn new skills, connect with venture investors, broaden their industry network, and access new markets. Examples of popular programs include “Investor Network” which connects qualified companies seeking early-stage funding with the first pan-European consortium of more than 80 healthcare investors, or “EIT Health Bootcamps” which runs incubation programs for start-ups. https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/d9fa0240-3c64-466f-8f1a-9cef77abc2cb/life-logo.png Our Offer_B - Life The LIFE programme is the EU's funding instrument for the environment and climate action. The most interesting offer to businesses is funding to large-scale demonstration projects that pilot new ground-breaking technologies and processes with clear positive environmental impact. Examples of relevant fields include circular economy, waste management, water preservation, etc. Grant: EUR 3-5 million https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/ee7b58b2-dd8c-407d-825d-245baaf38170/vinnova-logo.png Our Offer_B - Vinnova Vinnova is Sweden’s innovation agency that funds research and innovation projects that can benefit society. The programs include single applicant funding schemes, as well as funding directed towards value-adding consortia of partners and stakeholders from industrial value chains. Grant: EUR 0.2-2 million https://images.squarespace-cdn.com/content/v1/6242b554689a6641ee5f70ea/b55e0e63-8c24-47fd-b251-b8011d43e358/swedish-energy-agency-logo.png Our Offer_B - Swedish Energy Agency The Swedish Energy Agency supports research and development projects in the fields of supply, conversion, distribution and use of energy. Funding is also provided to development of new green and sustainable technologies and processes. Grant: EUR 0.4-5 million https://gaeu.com/corporate-finance daily 0.75 2023-08-16 https://gaeu.com/client-references daily 0.75 2026-02-18 https://gaeu.com/client-references/minalyze monthly 0.5 2022-06-01 https://gaeu.com/client-references/vicore-pharma monthly 0.5 2024-04-23 https://gaeu.com/client-references/cellink monthly 0.5 2024-04-23 https://gaeu.com/client-references/climate-recovery monthly 0.5 2022-06-01 https://gaeu.com/client-references/colzyx monthly 0.5 2024-03-21 https://gaeu.com/client-references/immunovia monthly 0.5 2024-04-23 https://gaeu.com/client-references/betagenon monthly 0.5 2022-06-01 https://gaeu.com/client-references/cinnober monthly 0.5 2024-04-23 https://gaeu.com/client-references/combigene monthly 0.5 2024-04-23 https://gaeu.com/client-references/senzagen monthly 0.5 2024-04-23 https://gaeu.com/client-references/corline-biomedical monthly 0.5 2024-04-23 https://gaeu.com/client-references/ilya-pharma monthly 0.5 2022-06-01 https://gaeu.com/client-references/klaria monthly 0.5 2024-04-23 https://gaeu.com/client-references/idogen monthly 0.5 2024-04-23 https://gaeu.com/client-references/scandinavian-biopharma monthly 0.5 2022-06-01 https://gaeu.com/client-references/targeted-immunotherapies monthly 0.5 2022-06-01 https://gaeu.com/client-references/verigraft monthly 0.5 2022-06-01 https://gaeu.com/client-references/cytacoat monthly 0.5 2022-06-01 https://gaeu.com/client-references/gradientech monthly 0.5 2022-06-01 https://gaeu.com/client-references/pila-pharma monthly 0.5 2022-06-01 https://gaeu.com/client-references/surgical-science monthly 0.5 2022-06-01 https://gaeu.com/client-references/ellen monthly 0.5 2022-06-01 https://gaeu.com/client-references/aerocrine monthly 0.5 2022-06-01 https://gaeu.com/client-references/clinical-laserthermia-systems monthly 0.5 2024-04-23 https://gaeu.com/client-references/scandinavian-realheart monthly 0.5 2024-04-23 https://gaeu.com/client-references/nelson-garden monthly 0.5 2022-06-01 https://gaeu.com/client-references/opsis monthly 0.5 2022-06-01 https://gaeu.com/client-references/cellcomb monthly 0.5 2022-06-01 https://gaeu.com/client-references/nord-west-yacht monthly 0.5 2022-06-01 https://gaeu.com/client-references/huhnseal monthly 0.5 2022-06-01 https://gaeu.com/client-references/prismatic-sensors monthly 0.5 2022-06-01 https://gaeu.com/client-references/mse-omnifinity monthly 0.5 2022-06-01 https://gaeu.com/client-references/upstream monthly 0.5 2022-06-01 https://gaeu.com/client-references/adverty monthly 0.5 2022-06-01 https://gaeu.com/client-references/minut monthly 0.5 2022-06-01 https://gaeu.com/client-references/irras monthly 0.5 2024-04-23 https://gaeu.com/client-references/pulpac monthly 0.5 2022-10-04 https://gaeu.com/client-references/multi4 monthly 0.5 2022-06-01 https://gaeu.com/client-references/qlucore monthly 0.5 2024-04-23 https://gaeu.com/client-references/jondetech monthly 0.5 2024-04-23 https://gaeu.com/client-references/elicera monthly 0.5 2024-04-23 https://gaeu.com/client-references/cellevate monthly 0.5 2024-03-21 https://gaeu.com/client-references/genagon monthly 0.5 2022-10-27 https://gaeu.com/client-references/greeniron monthly 0.5 2022-11-16 https://gaeu.com/client-references/lindhe-xtend monthly 0.5 2022-12-20 https://gaeu.com/client-references/seatwirl monthly 0.5 2024-04-23 https://gaeu.com/client-references/cyto365 monthly 0.5 2022-12-20 https://gaeu.com/client-references/embedl monthly 0.5 2023-02-09 https://gaeu.com/client-references/ligna-energy monthly 0.5 2023-02-10 https://gaeu.com/client-references/inossia monthly 0.5 2023-04-20 https://gaeu.com/client-references/multi4-medical-ab monthly 0.5 2023-04-20 https://gaeu.com/client-references/compular monthly 0.5 2024-02-28 https://gaeu.com/client-references/braincool monthly 0.5 2024-07-15 https://gaeu.com/client-references/pharmnovo monthly 0.5 2025-02-18 https://gaeu.com/client-references/alzecurepharma monthly 0.5 2025-06-30 https://gaeu.com/client-references/pixelgen-technologies monthly 0.5 2026-01-05 https://gaeu.com/client-references/linnovation monthly 0.5 2026-02-18 https://gaeu.com/client-references/westra monthly 0.5 2026-02-18